secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001651308-25-000084
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BeiGene shareholders re-elect all director nominees and approve share issuance/repurchase mandates at AGM
--------------------------------------------------------------------------------

- Re-elected directors Hooper (956M for), Krishana (890M for), Wang (987M for), Yi (846M for), Sharp (985M for).
- Approved 20% share issuance mandate (718M for, 277M against) and 10% share repurchase mandate (995M for, 99K against).
- Approved Connected Person Placing Authorization for Amgen to maintain shareholding for up to 5 years, renewable annually.
- Ratified Ernst & Young as independent auditors for FY2025 (989M for, 6M against).
- Advisory say-on-pay passed with 875M for, 120M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130825000084/0001651308-25-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130825000084/bgne-20250521.htm
  HTML page:      https://secwatch.observer/filing/0001651308-25-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer